SMI Expanded
1.757,82
PKT
-5,41
PKT
-0,31
%
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.01.22 | Richemont Overweight | Barclays Capital | |
| 11.01.22 | Roche Buy | Deutsche Bank AG | |
| 11.01.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 11.01.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 11.01.22 | ams-OSRAM Overweight | JP Morgan Chase & Co. | |
| 11.01.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 10.01.22 | Richemont Outperform | RBC Capital Markets | |
| 10.01.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.01.22 | DocMorris Buy | Jefferies & Company Inc. | |
| 07.01.22 | UBS Neutral | UBS AG | |
| 07.01.22 | Novartis Neutral | UBS AG | |
| 07.01.22 | UBS Outperform | RBC Capital Markets | |
| 07.01.22 | UBS Sector Perform | RBC Capital Markets | |
| 06.01.22 | Richemont Buy | Goldman Sachs Group Inc. | |
| 06.01.22 | Zurich Insurance Hold | Deutsche Bank AG | |
| 06.01.22 | Swiss Re Hold | Deutsche Bank AG | |
| 06.01.22 | UBS Buy | Jefferies & Company Inc. | |
| 06.01.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 06.01.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 05.01.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 05.01.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 04.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.01.22 | Roche Outperform | Bernstein Research | |
| 04.01.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 23.12.21 | Holcim Buy | Goldman Sachs Group Inc. | |
| 23.12.21 | Holcim Neutral | JP Morgan Chase & Co. | |
| 23.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 23.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.12.21 | DocMorris Buy | Warburg Research | |
| 21.12.21 | DocMorris Add | Baader Bank | |
| 21.12.21 | ams-OSRAM Buy | Kepler Cheuvreux | |
| 21.12.21 | DocMorris Buy | Jefferies & Company Inc. | |
| 21.12.21 | DocMorris Buy | Warburg Research | |
| 21.12.21 | DocMorris Buy | Baader Bank | |
| 20.12.21 | Novartis Buy | Jefferies & Company Inc. | |
| 20.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.12.21 | Clariant Equal Weight | Barclays Capital | |
| 17.12.21 | Holcim Buy | UBS AG | |
| 17.12.21 | Novartis Sell | Deutsche Bank AG | |
| 17.12.21 | Clariant Neutral | Goldman Sachs Group Inc. |